GG Yegutkin - Critical reviews in biochemistry and molecular …, 2014 - Taylor & Francis
Extracellular nucleotides and nucleosides mediate diverse signaling effects in virtually all organs and tissues. Most models of purinergic signaling depend on functional interactions …
Q Zhou, D Yang, AK Ombrello… - … England Journal of …, 2014 - Mass Medical Soc
Background We observed a syndrome of intermittent fevers, early-onset lacunar strokes and other neurovascular manifestations, livedoid rash, hepatosplenomegaly, and systemic …
P Navon Elkan, SB Pierce, R Segel… - … England Journal of …, 2014 - Mass Medical Soc
Background Polyarteritis nodosa is a systemic necrotizing vasculitis with a pathogenesis that is poorly understood. We identified six families with multiple cases of systemic and …
R Caorsi, F Penco, A Grossi, A Insalaco… - Annals of the …, 2017 - ard.bmj.com
Objectives To analyse the prevalence of CECR1 mutations in patients diagnosed with early onset livedo reticularis and/or haemorrhagic/ischaemic strokes in the context of inflammation …
RADAR is a two-protein bacterial defense system that was reported to defend against phage by" editing" messenger RNA. Here, we determine cryo-EM structures of the RADAR defense …
G Zhulai, E Oleinik, M Shibaev, K Ignatev - Biomolecules, 2022 - mdpi.com
The immunosuppressive effect of adenosine in the microenvironment of a tumor is well established. Presently, researchers are developing approaches in immune therapy that …
SPH Alexander, HE Benson… - British Journal of …, 2013 - Wiley Online Library
Abstract The Concise Guide to PHARMACOLOGY 2013/14 provides concise overviews of the key properties of over 2000 human drug targets with their pharmacology, plus links to an …
AV Zavialov, E Gracia, N Glaichenhaus… - Journal of leukocyte …, 2010 - academic.oup.com
Discovery of the growth factor activity of ADA2. ADAs play a pivotal role in regulating the level of adenosine, a signaling molecule controlling a variety of cellular responses by …
B Pinto, P Deo, S Sharma, A Syal, A Sharma - Clinical Rheumatology, 2021 - Springer
Deficiency of adenosine deaminase 2 (DADA2) is a monogenic disease caused by biallelic mutations in ADA2 gene (previously CECR1). The aim of this review was to describe the …